STRATEC Biomedical AG (SBSG)

Currency in EUR
26.750
-1.050(-3.78%)
Closed·
SBSG Scorecard
Full Analysis
Stock has taken a big hit over the last week
SBSG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
26.55027.900
52 wk Range
21.00045.300
Key Statistics
Bid/Ask
26.80 / 26.90
Prev. Close
27.8
Open
27.9
Day's Range
26.55-27.9
52 wk Range
21-45.3
Volume
11.56K
Average Volume (3m)
11K
1-Year Change
-31.41%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SBSG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
40.500
Upside
+51.40%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

STRATEC Biomedical AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

STRATEC Biomedical AG Company Profile

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Employees
1387
Market
Germany

Compare SBSG to Peers and Sector

Metrics to compare
SBSG
Peers
Sector
Relationship
P/E Ratio
20.3x20.5x−0.5x
PEG Ratio
4.410.050.00
Price/Book
1.3x2.1x2.6x
Price / LTM Sales
1.3x1.7x3.2x
Upside (Analyst Target)
53.3%45.4%45.7%
Fair Value Upside
Unlock21.7%8.6%Unlock

Analyst Ratings

3 Buy
2 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 40.500
(+51.40% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.32%
Dividend Yield
2.24%
Industry Median 1.80%
Annualised payout
0.60
Paid annually
5-Years Growth
-6.51%
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.12 / --
Revenue / Forecast
60.40M / --
EPS Revisions
Last 90 days

SBSG Income Statement

People Also Watch

91.65
HAGG
-4.63%
62.210
CRDI
-3.74%
31.800
CBKG
-0.75%
141.30
ENX
-0.21%

FAQ

What Stock Exchange Does STRATEC Biomedical Trade On?

STRATEC Biomedical is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for STRATEC Biomedical?

The stock symbol for STRATEC Biomedical is "SBSG."

What Is the STRATEC Biomedical Market Cap?

As of today, STRATEC Biomedical market cap is 325.17M.

What Is STRATEC Biomedical's Earnings Per Share (TTM)?

The STRATEC Biomedical EPS (TTM) is 1.32.

When Is the Next STRATEC Biomedical Earnings Date?

STRATEC Biomedical will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is SBSG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has STRATEC Biomedical Stock Split?

STRATEC Biomedical has split 1 times.

How Many Employees Does STRATEC Biomedical Have?

STRATEC Biomedical has 1387 employees.

What is the current trading status of STRATEC Biomedical (SBSG)?

As of 02 Aug 2025, STRATEC Biomedical (SBSG) is trading at a price of 26.75, with a previous close of 27.80. The stock has fluctuated within a day range of 26.55 to 27.90, while its 52-week range spans from 21.00 to 45.30.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.